| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2021 | NBIX Neurocrine Biosciences Inc | Roberts Eiry49 | Chief Medical Officer | Sell | 2,632 | $111.06 | $292,297.29 | -14.2% | |
| Jan 8, 2021 | NBIX Neurocrine Biosciences Inc | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 308,250 | $110.22 | $33,973,876.51 | -25.9% | |
| Jan 8, 2021 | LQDA Liquidia Corp | Eshelman Ventures, LLC | 10% Owner | Sell | 214,721 | $3.11 | $667,146.62 | -1.7% | |
| Jan 8, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 123,739 | $0.24 | $29,334.15 | - | |
| Jan 7, 2021 | BSPK Bespoke Extracts, Inc. | Pollack Danil | CEO | Buy | 5,000,000 | $0.02 | $100,000.00 | +4.2% | |
| Jan 7, 2021 | CVSI Cv Sciences, Inc. | Mona Michael Joseph Jr | 10% Owner | Sell | 150,140 | $0.56 | $84,507.40 | -3.5% | |
| Jan 7, 2021 | COLL Collegium Pharmaceutical, Inc | Fleming Alison B | Chief Technology Officer | Sell | 19,378 | $22.17 | $429,652.00 | -8.0% | |
| Jan 6, 2021 | PRGO Perrigo Co Plc | Sorota Richard S | EVP &President Csca | Buy | 7,513 | $43.48 | $326,665.24 | New | |
| Jan 6, 2021 | PCRX Pacira Biosciences, Inc. | Reinhardt Max79 | President | Sell | 110 | $60.81 | $6,689.10 | -0.8% | |
| Jan 4, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 17,000 | $0.22 | $3,799.50 | - | |
| Dec 30, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 21,410 | $0.23 | $4,945.20 | - | |
| Dec 28, 2020 | BTAI Bioxcel Therapeutics, Inc. | O'Neill Vincent86 | Chief Medical Officer | Sell | 25,000 | $51.45 | $1,286,156.68 | -58.6% | |
| Dec 24, 2020 | ASRT Assertio Holdings, Inc. | Cr Group L.P. | 10% Owner | Sell | 8,767,185 | $0.37 | $3,270,818.82 | -78.6% | |
| Dec 24, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 42,000 | $0.25 | $10,346.00 | - | |
| Dec 22, 2020 | LQDA Liquidia Corp | Eshelman Ventures, LLC | 10% Owner | Sell | 7,949 | $3.14 | $24,959.86 | -0.1% | |
| Dec 22, 2020 | HROW Harrow, Inc. | Opaleye Management Inc.60 | - | Buy | 106,416 | $5.26 | $559,482.03 | +1.2% | |
| Dec 22, 2020 | ASRT Assertio Holdings, Inc. | Cr Group L.P. | 10% Owner | Sell | 2,500,000 | $0.35 | $877,400.00 | -7.6% | |
| Dec 21, 2020 | SCYX Scynexis Inc | Sukenick Scott | General Counsel | Buy | 1,600 | $6.25 | $10,000.00 | +21.3% | |
| Dec 21, 2020 | SCYX Scynexis Inc | Gilman Steven C70 | Director | Buy | 4,000 | $6.25 | $25,000.00 | New | |
| Dec 21, 2020 | SCYX Scynexis Inc | Anido Armando | Director | Buy | 5,000 | $6.25 | $31,250.00 | New | |
| Dec 21, 2020 | SCYX Scynexis Inc | Hanham Ann | Director | Buy | 3,200 | $6.25 | $20,000.00 | +758.3% | |
| Dec 21, 2020 | SCYX Scynexis Inc | Francois Eric | Chief Financial Officer | Buy | 600 | $6.25 | $3,750.00 | +5.4% | |
| Dec 21, 2020 | SCYX Scynexis Inc | Tinmouth Brian Philippe | Director | Buy | 8,000 | $6.25 | $50,000.00 | New | |
| Dec 21, 2020 | SCYX Scynexis Inc | Angulo Gonzalez David | Chief Medical Officer | Buy | 1,600 | $6.25 | $10,000.00 | +7.2% | |
| Dec 21, 2020 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 40,000 | $6.25 | $250,000.00 | +57.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.